The sodium-glucose cotransporter 2 inhibitor luseogliflozin can suppress muscle atrophy in Db/Db mice by suppressing the expression of foxo1

We investigated the effect of the sodium glucose cotransporter-2 inhibitor (SGLT-2i) luseogliflozin on skeletal muscle. Eight-week-old mice were fed a standard diet or the standard diet with added luseogliflozin for 8 weeks. The mice were divided into the following four genotype/dietary groups: Db/m...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Clin Biochem Nutr
Egile Nagusiak: Okamura, Takuro, Hashimoto, Yoshitaka, Osaka, Takafumi, Fukuda, Takuya, Hamaguchi, Masahide, Fukui, Michiaki
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: the Society for Free Radical Research Japan 2019
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6667382/
https://ncbi.nlm.nih.gov/pubmed/31379410
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3164/jcbn.18-114
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak